- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06268249
Ulinastatin Improves Post-Cardiac Surgery Cognitive Dysfunction
Ulinastatin Improves Post-Cardiac Surgery Cognitive Dysfunction by Inhibiting Glycocalyx Degradation: An Observational Study
Study Overview
Detailed Description
Baseline Period Visit 1 (within 24 hours before surgery)
Sign informed consent Check inclusion/exclusion criteria Demographic data (sex, age, occupation, etc.) Past medical history (stroke, hypertension, diabetes, dyslipidemia, coronary heart disease, diabetes, etc.) and medication history in the past 3 months Vital signs (temperature, pulse, respiration, blood pressure) Preoperative ECG Preoperative echocardiography Laboratory tests (blood routine, blood glucose, blood lipids, liver and kidney function, myocardial enzymes, blood electrolytes, coagulation function) Concomitant therapy Adverse events
Intraoperative cardiopulmonary bypass
Record vital signs and various physiological indicators in the operating room. Routinely perform central venous puncture to establish venous access and monitor central venous pressure, and radial artery puncture to monitor invasive arterial pressure.
After general anesthesia and endotracheal intubation, routine blood chemistry and arterial blood gas analysis were performed.
After collecting the above blood samples for testing, the remaining blood was centrifuged, and the plasma was frozen at -80°C for subsequent testing (levels of CRP, IL-6, IL-10, TNF-α, TK/B1R/MMP3, etc.).
Operation time Vital signs (temperature, pulse, respiration, blood pressure) Routine blood chemistry and arterial blood gas analysis Document vasoactive drug use
24 hours, 72 hours, 7 days after surgery
Vital signs (temperature, pulse, respiration, blood pressure) Bedside echocardiography Laboratory tests (blood routine, blood sugar, blood lipids, liver and kidney function, myocardial enzymes, coagulation function, etc.) After collecting the above blood samples for testing, the remaining blood is centrifuged, and the plasma is frozen at -80°C for later testing (levels of glycocalyx) POCD Document treatment regimen (including vasoactive drug use, etc.)
- Follow-up period
CCU time and total hospital stay 28-day survival status The survival status of the patients was followed up, and the date of death and the cause of death should be recorded in the patients who died.
Research Evaluation Analyze the clinical correlation between glycocalyx and its related indicators and postoperative cognitive dysfunction after cardiac surgery.
Patient Completion/Withdrawal from Study Finish All evaluation data of the patients 28 days after the operation were completely collected and considered as completed cases.
Inclusion criteria:
Voluntary participation in the study; Age ≥ 18 years and ≤ 80 years; Patients undergoing heart surgery: (coronary artery bypass grafting, heart valve replacement surgery, Morrow procedure, aortic dissection surgery).
Exclusion criteria:
Patients experiencing adverse events during the surgery; Recipients of solid organ or bone marrow transplants; Patients with autoimmune diseases, tumors, or who have received high-dose steroids or immunosuppressive therapy within the past 2 months; Deemed unsuitable for participation in this study by the researchers. Primary outcome: postoperative cognitive dysfunction. Objective: Analyze the correlation between polysaccharide coating and cardiac surgery-related indicators.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Hubei
-
Wuhan, Hubei, China, 430030
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Voluntary participation in the study;
- Age ≥ 18 years and ≤ 80 years;
- Patients undergoing heart surgery: (coronary artery bypass grafting, heart valve replacement surgery, Morrow procedure, aortic dissection surgery).
Exclusion Criteria:
- Patients experiencing adverse events during the surgery;
- Recipients of solid organ or bone marrow transplants;
- Patients with autoimmune diseases, tumors, or who have received high-dose steroids or immunosuppressive therapy within the past 2 months;
- Deemed unsuitable for participation in this study by the researchers.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
POCD - Postoperative Cognitive Dysfunction
Time Frame: 24 hours
|
Mini-Mental State Examination(MMSE)
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Survival time
Time Frame: 28 days
|
Questionnaire
|
28 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TJ-IRB20231224
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Complication
-
Medical University of GdanskUniversity Clinical Centre, Gdansk; EIT HealthRecruitingCardiac Complication | Perioperative ComplicationPoland
-
Turkiye Yuksek Ihtisas Education and Research HospitalCompletedCardiac Procedure ComplicationTurkey
-
Riphah International UniversityNot yet recruitingCardiac Procedure ComplicationPakistan
-
Abbott Medical DevicesCompletedComplication of Cardiac DefibrillatorItaly
-
Xijing HospitalUnknownIntubation Complication | Complication of Ventilation Therapy | Postoperative; Dysfunction Following Cardiac Surgery
-
China-Japan Friendship HospitalUnknownMechanical Complication of Cardiac PacemakerChina
-
Shahid Beheshti University of Medical SciencesUnknownVenous Occlusion | Complication of Cardiac Defibrillator | Disorder of Cardiac Pacemaker SystemIran, Islamic Republic of
-
The Cleveland ClinicPhilips HealthcareCompletedMechanical Complication of Cardiac Electronic DeviceUnited States, Germany
-
Medical University of ViennaUnknownLate Complication From Cardiac Pacemaker ImplantationAustria
-
Universidade Federal de Santa MariaCompletedComplication, Postoperative | Cardiac ComplicationBrazil
Clinical Trials on Ulinastatin
-
Konkuk University Medical CenterCompletedCardiac Surgery | Cardiopulmonary BypassKorea, Republic of
-
Huashan HospitalNot yet recruiting
-
Jinnah Postgraduate Medical CentreRecruitingSeptic Shock | Severe Sepsis | MODSPakistan
-
Nanfang Hospital of Southern Medical UniversityDongguan People's Hospital; Foshan Hospital of Traditional Chinese Medicine; Shenzhen... and other collaboratorsRecruitingInflammatory Response | ECMOChina
-
Yonsei UniversityCompletedAbnormal Aortic ValveKorea, Republic of
-
Huazhong University of Science and TechnologyNot yet recruitingNondepolarising Muscle RelaxantsChina
-
Ajou University School of MedicineUnknown
-
Yonsei UniversityCompleted
-
Peking Union Medical College HospitalTechpool Bio-Pharma Co., Ltd.CompletedSepsis | Septic ShockChina